Literature DB >> 19019155

Ubiquitin-dependent and -independent mitochondrial protein quality controls: implications in ageing and neurodegenerative diseases.

Doris Germain1.   

Abstract

The ubiquitin-independent protein quality control of matrix proteins of the mitochondrion is well characterized and until recently the mitochondrion was considered a 'ubiquitination-free' organelle. However, a number of studies now indicate multiple roles of the ubiquitin-proteasome pathway in the regulation and maintenance of mitochondrial integrity. Of particular interest to this review is the finding of a mitochondrial ubiquitin-dependent protein quality control and that this pathway may share similarity to the endoplasmic reticulum-associated degradation (ERAD) pathway that acts to eliminate misfolded proteins from the lumen of the endoplasmic reticulum. The potential cross-talk between the ubiquitin-dependent and -independent protein quality controls and their implications in ageing and neurodegenerative diseases, notably in Parkinson's disease, are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019155     DOI: 10.1111/j.1365-2958.2008.06502.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  12 in total

1.  Regulation of mitochondrial processes: a target for heart failure.

Authors:  Suresh Selvaraj Palaniyandi; Xin Qi; Gouri Yogalingam; Julio Cesar Batista Ferreira; Daria Mochly-Rosen
Journal:  Drug Discov Today Dis Mech       Date:  2010

2.  Mitochondrial stress and the pathogenesis of diabetic neuropathy.

Authors:  Paul Fernyhough; Subir K Roy Chowdhury; Robert E Schmidt
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01-01

3.  MicroRNA-137 is a novel hypoxia-responsive microRNA that inhibits mitophagy via regulation of two mitophagy receptors FUNDC1 and NIX.

Authors:  Wen Li; Xingli Zhang; Haixia Zhuang; He-ge Chen; Yinqin Chen; Weili Tian; Wenxian Wu; Ying Li; Sijie Wang; Liangqing Zhang; Yusen Chen; Longxuan Li; Bin Zhao; Senfang Sui; Zhe Hu; Du Feng
Journal:  J Biol Chem       Date:  2014-02-26       Impact factor: 5.157

Review 4.  Glucocerebrosidase is shaking up the synucleinopathies.

Authors:  Marina Siebert; Ellen Sidransky; Wendy Westbroek
Journal:  Brain       Date:  2014-02-14       Impact factor: 13.501

5.  TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins.

Authors:  M R Amoroso; D S Matassa; G Laudiero; A V Egorova; R S Polishchuk; F Maddalena; A Piscazzi; S Paladino; D Sarnataro; C Garbi; M Landriscina; F Esposito
Journal:  Cell Death Differ       Date:  2011-10-07       Impact factor: 15.828

6.  Proteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI.

Authors:  Xing'an Li; Yingjiu Zhang; Peng Xie; Jinhua Piao; Yihong Hu; Ming Chang; Tao Liu; Linsen Hu
Journal:  BMC Neurosci       Date:  2010-08-12       Impact factor: 3.288

7.  Postnatal proteasome inhibition induces neurodegeneration and cognitive deficiencies in adult mice: a new model of neurodevelopment syndrome.

Authors:  Rocío Romero-Granados; Ángela Fontán-Lozano; Francisco Javier Aguilar-Montilla; Ángel Manuel Carrión
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

8.  The Degradation Pathway of the Mitophagy Receptor Atg32 Is Re-Routed by a Posttranslational Modification.

Authors:  Mariia Levchenko; Isotta Lorenzi; Jan Dudek
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

9.  Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy.

Authors:  Matthew E Gegg; J Mark Cooper; Kai-Yin Chau; Manuel Rojo; Anthony H V Schapira; Jan-Willem Taanman
Journal:  Hum Mol Genet       Date:  2010-09-24       Impact factor: 6.150

Review 10.  PINK1 function in health and disease.

Authors:  Emma Deas; Helene Plun-Favreau; Nicholas W Wood
Journal:  EMBO Mol Med       Date:  2009-06       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.